Literature DB >> 19006818

D1-like dopamine receptors regulate GABAA receptor function to modulate hippocampal neural progenitor cell proliferation.

Darren Goffin1, Johan Aarum, Jörn E Schroeder, Jasmina N Jovanovic, Tsu Tshen Chuang.   

Abstract

The proliferation and differentiation of neural progenitor (NP) cells can be regulated by neurotransmitters including GABA and dopamine. The present study aimed to examine how these two neurotransmitter systems interact to affect post-natal hippocampal NP cell proliferation in vitro. Mouse hippocampal NP cells express functional GABAA receptors, which upon activation led to an increase in intracellular calcium levels via the opening of L-type calcium channels. Activation of these GABAA receptors also caused a significant decrease in proliferation; an effect that required the entry of calcium through L-type calcium channels. Furthermore, while activation of D1-like dopamine receptors had no effect on proliferation, it abrogated the suppressive effects of GABAA receptor activation on proliferation. The effects of D1-like dopamine receptors are associated with a decrease in the ability of GABAA receptors to increase intracellular calcium levels, and a reduction in the surface expression of GABAA receptors. In this way, D1-like dopamine receptor activation can increase the proliferation of NP cells by preventing GABAA receptor-mediated inhibition of proliferation. These results suggest that, in conditions where NP cell proliferation is under the tonic suppression of GABA, agonists which act through D1-like dopamine receptors may increase the proliferation of neural progenitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19006818     DOI: 10.1111/j.1471-4159.2008.05679.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Modulation of Postnatal Neurogenesis by Perinatal Asphyxia: Effect of D1 and D2 Dopamine Receptor Agonists.

Authors:  A Tapia-Bustos; R Perez-Lobos; V Vío; C Lespay-Rebolledo; E Palacios; A Chiti-Morales; D Bustamante; M Herrera-Marschitz; P Morales
Journal:  Neurotox Res       Date:  2016-09-16       Impact factor: 3.911

2.  Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis.

Authors:  Jingxian Yang; Yaping Yan; Cun-Gen Ma; Tingguo Kang; Nan Zhang; Bruno Gran; Hui Xu; Ke Li; Bogoljub Ciric; Andro Zangaladze; Mark Curtis; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Acta Neuropathol       Date:  2012-04-22       Impact factor: 17.088

3.  GABAergic control of neurite outgrowth and remodeling during development and adult neurogenesis: general rules and differences in diverse systems.

Authors:  Evelyne Sernagor; François Chabrol; Guillaume Bony; Laura Cancedda
Journal:  Front Cell Neurosci       Date:  2010-04-14       Impact factor: 5.505

4.  Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells.

Authors:  Jingxian Yang; Yaping Yan; Yang Xia; Tingguo Kang; Xing Li; Bogoljub Ciric; Hui Xu; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Mol Ther       Date:  2013-10-17       Impact factor: 11.454

5.  Dopamine-induced plasticity, phospholipase D (PLD) activity and cocaine-cue behavior depend on PLD-linked metabotropic glutamate receptors in amygdala.

Authors:  Balaji Krishnan; Kathy M Genzer; Sebastian W Pollandt; Jie Liu; Joel P Gallagher; Patricia Shinnick-Gallagher
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

6.  The effects of etomidate and midazolam on adipose tissue-derived mesenchymal stem cell proliferation.

Authors:  Ho Park; Kyoungho Ryu; Yun-Hong Kim; Won-Jun Choi; Dongchan Ko
Journal:  Korean J Anesthesiol       Date:  2016-09-08

7.  Early onset of inflammation during ontogeny of bipolar disorder: the NLRP2 inflammasome gene distinctly differentiates between patients and healthy controls in the transition between iPS cell and neural stem cell stages.

Authors:  D Vizlin-Hodzic; Q Zhai; S Illes; K Södersten; K Truvé; T Z Parris; P K Sobhan; S Salmela; S T Kosalai; C Kanduri; J Strandberg; H Seth; T O Bontell; E Hanse; H Ågren; K Funa
Journal:  Transl Psychiatry       Date:  2017-01-24       Impact factor: 6.222

8.  In Vitro and In Silico Characterization of Kurarinone as a Dopamine D1A Receptor Antagonist and D2L and D4 Receptor Agonist.

Authors:  Ritu Prajapati; Su Hui Seong; Pradeep Paudel; Se Eun Park; Hyun Ah Jung; Jae Sue Choi
Journal:  ACS Omega       Date:  2021-12-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.